| External factors: | Cilostazol |
| Aging type: | Prevent |
| Aging characteristic: |
| Category: | Chemical compounds |
| Phenotype: | Aging |
| Experiment: | SA-β-gal activity assay |
| Description: | Treatment with cilostazol inhibited the senescent phenotype induced by sirolimus or everolimus at 10 days. Under treatment with sirolimus or everolimus (2.5 nmol/l), 49.2% or 53.0% of cells were SA-βgal positive, versus only 13.6% or 14.6% of cilostazol (100 μmol/l)-treated cells under the same conditions. |
| Regulatory pathway: | -- |
| R-EF-Pathway: | -- |
| Pathway experiment: | -- |
| Pathway description: | -- |
Annotation: